Salvinorin A: Composition, Structure, and Effects

Categories : Salvia Divinorum

Salvinorin A is the primary phytoactive compound found in the leaves of Salvia divinorum, a plant of the Lamiaceae family originating from the Sierra Mazateca of Oaxaca, Mexico. Chemically and pharmacologically, it is a unique molecule within the plant kingdom: it is not an alkaloid, contains no nitrogen in its structure, and acts on a receptor system distinct from classical psychedelics. If you want to learn about the historical and botanical context of the plant, you can also check our comprehensive guide on Salvia divinorum. In this article, we analyze the chemical structure of salvinorin A, its mechanism of action, its natural concentration in the leaf, and the different formats available in the Edabea catalog.


Chemical Classification — a Terpenoid, Not an Alkaloid

Salvinorin A (C23H28O8) is a neoclerodane diterpene — a 20-carbon terpenoid with a complex polycyclic structure. It was first isolated and identified by Valdés, Diaz, and Paul in 1984, who initially named it "divinorin A" before the name "salvinorin A" was established as standard (Valdés, L.J. et al., 1984. Journal of Organic Chemistry, 49(24), 4716–4720).

The structural difference from alkaloids is noteworthy: alkaloids contain nitrogen in their structure and form the chemical basis of most known plant psychoactive compounds — morphine, cocaine, psilocybin, DMT. Salvinorin A contains no nitrogen, making it the first identified non-alkaloid natural psychoactive compound found in plants.

Its lipophilic nature — high solubility in lipids — allows it to rapidly cross the blood-brain barrier, explaining the swift onset of its pharmacological effects following administration.

Molecular structure of salvinorin A (C23H28O8)

Molecular structure of salvinorin A (C23H28O8). Source: Valdés et al., 1984.


Mechanism of Action — Kappa Opioid Receptors

Salvinorin A acts as a potent and selective agonist of kappa opioid receptors (KOR), a mechanism of action that radically distinguishes it from all other known natural psychoactive compounds. This mechanism was described by Roth et al. in 2002, who established that salvinorin A has a high affinity for KOR without significant affinity for serotoninergic 5-HT2A receptors — the central mechanism of classical psychedelics like psilocybin, LSD, or DMT (Roth, B.L. et al., 2002. PNAS, 99(18), 11934–11939).

Kappa opioid receptors differ from mu opioid receptors (MOR), which are acted upon by morphine and opiates. They are distributed throughout the central and peripheral nervous system, with a distinct presence in the prefrontal cortex, limbic system, and spinal cord, and are involved in the modulation of pain, mood, and perceptual processes.

The potency of salvinorin A on KOR is significantly greater than that of other known kappa agonists, making it a valuable research tool for the study of this receptor system.


Natural Concentration in the Leaf of Salvia divinorum

In the dried leaf of Salvia divinorum, the natural concentration of salvinorin A ranges from 0.89 to 3.87 mg per gram of dry material, with a documented average of around 2.5 mg/g (Valdés, L.J. et al., 1994. Journal of Ethnopharmacology, 43(3), 171–179). This variability depends on the plant's geographical origin, cultivation conditions, harvesting times, and the drying process.

Mature leaves typically exhibit higher concentrations than young ones. Salvinorin A primarily accumulates in the capitate and tectorial trichomes of the leaf surface, explaining why the processing of the leaf (drying, grinding) can affect the concentration available in the final material.


Other Compounds in Salvia divinorum

Although salvinorin A is the main active compound and the only one with well-documented pharmacological activity on KOR, the leaf of Salvia divinorum contains other related compounds from the salvinorin family: salvinorin B, salvinorin C, salvinorin D, salvinos and various flavonoids. Salvinorin B is the most studied after A; it does not exhibit significant activity on KOR and its pharmacological role is not fully established. The ensemble of these compounds forms the complete phytochemical profile of the leaf, differing from the profiles of standardized extracts.


Available Formats — Dried Leaves and Standardized Extracts

In the Edabea catalog, salvinorin A is available in two main formats: dried leaves, with variable documented natural concentration (0.89–3.87 mg/g), and standardized extracts, which concentrate the active compound through solvent extraction and reapplication onto a plant base.

Standardized extracts of Salvia divinorum 5X to 80X

Format Approximate Salvinorin A Standardization Sheet
Dried Leaf 0.89–3.87 mg/g (natural, variable) No View Leaves
Extract 5X ~12.5 mg/g Yes View
Extract 10X ~25 mg/g Yes View
Extract 20X ~50 mg/g Yes View
Extract 30X ~75 mg/g Yes View
Extract 40X ~100 mg/g Yes View
Extract 80X ~288 mg/g Yes View

For a detailed description of the extraction process and the differences between leaf and extract, you can consult our article on differences between leaves and extracts of Salvia divinorum. To see the complete pack of extracts from the 5X–80X scale, access the Edabea extracts pack.


Current Scientific Interest

Salvinorin A has generated increasing interest in pharmacology and neuroscience for several reasons. It is the only non-nitrogenous natural psychoactive compound identified with documented high activity on KOR. Its mechanism of action, completely different from that of classical serotoninergic psychedelics, makes it a useful tool for differentiating studies of the opioid and serotonin systems in the modulation of perception and consciousness.

Some preclinical studies have investigated the potential of KOR agonists — with salvinorin A as a reference — in the context of mood disorders and depression, although results are preliminary and the KOR mechanism has complex activity profiles that complicate direct clinical translation. Current research is mainly basic and experimental.


Legal Status

Salvinorin A is included in the lists of controlled substances in various jurisdictions. It is the purchaser's responsibility to verify the applicable regulations in their place of residence prior to acquiring any related products. Edabea products are marketed exclusively as botanical collection materials and ethnobotanical research.


Frequently Asked Questions about Salvinorin A

Why is Salvinorin A pharmacologically unique?

For three cumulative reasons: it is a terpenoid, not an alkaloid — which excludes it from the chemical group of practically all known natural psychoactive compounds; it does not act on serotoninergic 5-HT2A receptors which characterize classical psychedelics (psilocybin, LSD, DMT); and it acts as a selective agonist of kappa opioid receptors, a unique mechanism among plant-derived compounds. This combination makes it the only molecule of its kind identified in plants to date.

What is the difference between Salvinorin A and Salvinorin B?

Salvinorin B is a closely related compound structurally to Salvinorin A — also a neoclerodane diterpene found in Salvia divinorum — but with a key difference: it lacks significant affinity for kappa opioid receptors. Salvinorin B does not exhibit the documented pharmacological activity of Salvinorin A on KOR and its role in the phytochemical profile of the plant is not fully established. The dried leaf contains both compounds; standardized extracts primarily concentrate Salvinorin A because of solubility differences in the extraction process.

Why do extracts have such different concentrations compared to the leaf?

Standardized extracts are obtained by selectively dissolving Salvinorin A from the leaf with lipophilic organic solvents (acetone, isopropyl alcohol), evaporating the solvent, and reapplying the extract onto a plant base in the proportion corresponding to the desired concentration level. A 5X extract concentrates approximately 12.5 mg/g, versus the average of ~2.5 mg/g of the dried leaf. The 80X extract reaches ~288 mg/g — about 115 times more than the average concentration of the starting leaf material. For a detailed explanation of the process, see our article on differences between leaves and extracts.

Does Salvinorin A act like classical psychedelics?

No — it acts through a completely different mechanism. Classical psychedelics (psilocybin, LSD, DMT, mescaline) are agonists of serotoninergic 5-HT2A receptors. Salvinorin A has no significant affinity for these receptors and selectively acts on kappa opioid receptors (KOR), a distinct receptor system with different locations and functions within the central nervous system. This explains why the activity profile of Salvinorin A is qualitatively different from that of serotoninergic psychedelics, despite producing perceptual alterations (Roth et al., 2002, op. cit.).

Is Salvinorin A the only known non-alkaloid natural psychoactive substance?

Yes — as of the publication date of this article, Salvinorin A is the only well-documented natural psychoactive compound of plant origin that does not belong to the alkaloid group. All other widely studied plant psychoactive compounds — morphine, cocaine, psilocybin, DMT, mescaline, ibogaine, scopolamine — are alkaloids containing nitrogen in their structure. Salvinorin A is the documented and recognized exception in specialized pharmacological literature.


About this content

Article prepared by the specialized team of Edabea Natura, with over 15 years of experience in selection and marketing of ethnobotanical materials. The phytochemical and pharmacological information is based on the cited bibliographic sources. Last updated: April 2026.


Bibliographic References

  • Roth, B.L. et al. (2002). Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. PNAS, 99(18), 11934–11939.
  • Valdés, L.J. et al. (1984). Divinorin A, a psychotropic terpenoid, and divinorin B from the hallucinogenic Mexican mint Salvia divinorum. Journal of Organic Chemistry, 49(24), 4716–4720.
  • Valdés, L.J. et al. (1994). Ethnopharmacology of ska María Pastora (Salvia divinorum). Journal of Ethnopharmacology, 43(3), 171–179.
  • Wasson, R.G. (1962). A new Mexican psychotropic drug from the mint family. Botanical Museum Leaflets, Harvard, 20(3), 77–84.

Share this content